Cargando…
Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
AIM: The use of bevacizumab in combination therapy is an emerging trend in metastatic colorectal cancer treatment. However, the clinical value of different combination types remains under debate. Thus, a meta-analysis of randomized controlled trials (RCTs) comparing bevacizumab-based combination the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287670/ https://www.ncbi.nlm.nih.gov/pubmed/30584320 http://dx.doi.org/10.2147/OTT.S171724 |